Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes

References

• Ritz E. Kidney damage in metabolic syndrome: nip it in the bud. Am J Kidney Dis. 2009;53:726–9.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis. 2005;12:177–86.
   PubMed Web of Science ®Google Scholar
• Huo W, Zhang K, Nie Z, Li Q, Jin F. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev (Orlando). 2010;24:143–6.
   PubMedGoogle Scholar
• Li W, Yu Y, He H, Chen J, Zhang D. Urinary kidney injury molecule-1 as an early indicator to predict contrast-induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention. Biomed Rep. 2015;3:509–12. [Patternmatch]
   PubMed Web of Science ®Google Scholar
• Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009;32:91–8.
   PubMed Web of Science ®Google Scholar
• Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006;105:485–91.
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M, Bokenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem. 2007;40:946–51.
   PubMed Web of Science ®Google Scholar
• Koyner JL, Garg AX, Shlipak MG, Patel UD, Sint K, Hong K, et al. Urinary cystatin C and acute kidney injury after cardiac surgery. American J Kidney Dis. 2013;61:730–8.
   PubMed Web of Science ®Google Scholar
• Weir MR. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Clin Ther. 2007;29:1803–24.
   PubMed Web of Science ®Google Scholar
• Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med. 2006;44:288–91.
   PubMed Web of Science ®Google Scholar
• Byberg L, Zethelius B, McKeigue PM, Lithell HO. Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia. 2001;44:2134–9.
   PubMed Web of Science ®Google Scholar
• Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009;119:2765–71.
   PubMed Web of Science ®Google Scholar
• Nerpin E, Ingelsson E, Riserus U, Sundstrom J, Larsson A, Jobs E, et al. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men. Nephrol Dial Transplant. 2011;26:2820–7.
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase. Kidney Int. 2011;79:464–70.
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Larsson A, Helmersson-Karlqvist J, Lind L, Ingelsson E, Larsson TE, et al. Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men. Clin J Am Soc Nephrol. 2014;9:1393–401.
   PubMed Web of Science ®Google Scholar
• Conway BR, Manoharan D, Jenks S, Dear JW, McLachlan S, Strachan MW, et al. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors. Kidney Int. 2012;82:812–18.
   PubMed Web of Science ®Google Scholar
• Helmersson-Karlqvist J, Arnlov J, Carlsson AC, Harma J, Larsson A. Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort. Atherosclerosis. 2014;234:108–13.
   PubMed Web of Science ®Google Scholar
• Helmersson-Karlqvist J, Larsson A, Carlsson AC, Venge P, Sundstrom J, Ingelsson E, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. Atherosclerosis. 2013;227:408–13.
   PubMed Web of Science ®Google Scholar
• Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia. 2015;58:188–98.
   PubMed Web of Science ®Google Scholar
• Phillips AO. The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep. 2003;3:491–6.
   PubMedGoogle Scholar
• Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail. 2001;23:471–81.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627–37.
   PubMed Web of Science ®Google Scholar
• Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J Pathol. 2010;220:7–16.
   PubMed Web of Science ®Google Scholar
• Mimura I, Nangaku M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol. 2010;6:667–78.
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Larsson A, Helmersson-Karlqvist J, Lind L, Ingelsson E, Larsson TE, et al. Urinary kidney injury molecule 1 and incidence of heart failure in elderly men. European J Heart Fail. 2013;15:441–6.
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Calamia M, Riserus U, Larsson A, Helmersson-Karlqvist J, Lind L, et al. Kidney injury molecule (KIM)-1 is associated with insulin resistance: results from two community-based studies of elderly individuals. Diabetes Res Clin Pract. 2014;103:516–21.
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Rossing K, Hess G, Zdunek D, Jensen BR, Parving HH, et al. The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP. Scand J Clin Lab Invest. 2012;72:137–42.
   PubMed Web of Science ®Google Scholar